BioCardia Inc (BCDA)

2.94 +0.18 (+6.52%) USD  |  NASDAQ  |  Sep 27, 16:00
2.91 -0.03 (-1.02%) After-Hours: 20:00
More

BioCardia Research and Development Expense (TTM): 5.069M for June 30, 2024

Research and Development Expense (TTM) Chart

Historical Research and Development Expense (TTM) Data

View and export this data back to 2009. Upgrade now.
Date Value
June 30, 2024 5.069M
March 31, 2024 6.583M
December 31, 2023 7.726M
September 30, 2023 8.77M
June 30, 2023 9.042M
March 31, 2023 9.032M
December 31, 2022 8.834M
September 30, 2022 8.749M
June 30, 2022 8.845M
March 31, 2022 8.903M
December 31, 2021 8.558M
September 30, 2021 8.768M
June 30, 2021 9.002M
March 31, 2021 8.864M
December 31, 2020 9.809M
September 30, 2020 9.654M
June 30, 2020 9.187M
March 31, 2020 9.182M
December 31, 2019 8.562M
September 30, 2019 8.597M
June 30, 2019 8.852M
March 31, 2019 8.664M
December 31, 2018 8.453M
September 30, 2018 8.019M
June 30, 2018 7.457M
Date Value
March 31, 2018 6.721M
December 31, 2017 5.799M
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016
September 30, 2016
June 30, 2016
March 31, 2016
December 31, 2015
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013
September 30, 2013
June 30, 2013
March 31, 2013
December 31, 2012
September 30, 2012
June 30, 2012
March 31, 2012

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

5.069M
Minimum
Jun 2024
9.809M
Maximum
Dec 2020
8.587M
Average
8.840M
Median

Research and Development Expense (TTM) Benchmarks

Alnylam Pharmaceuticals Inc 1.080B
Theriva Biologics Inc 14.61M
Zevra Therapeutics Inc 46.33M
PetIQ Inc --
Instil Bio Inc 20.65M